Energy set up for volatility near term but is turning the corner long term, says Katie Stockton

Long-term large-cap energy outlook remains bullish, supported by higher WTI crude oil. But the surge in BKR and XOM makes short-term charts look stretched.
Mortgage rates jump sharply higher after Iran strikes, reversing last week’s decline

Mortgage rates moved decidedly higher Monday, as the U.S. war with Iran pushed oil prices up and treasury yields followed.
As Trump declares inflation tamed, Iran conflict threatens new price pressures

The conflict involving Iran threatens another price spike that could undermine the president’s central case for lower interest rates.
NYSE insider Jay Woods is watching these key levels on the S&P 500 and crude oil as U.S.-Iran conflict widens

Beyond the war, this week will see a highly-awaited February jobs report along with key earnings from Target, Broadcom and beaten-down CrowdStrike.
Berkshire Hathaway shares drop more than 4% after poor fourth-quarter results, no bold moves by new CEO Abel

Some had hoped for more aggressive signals on capital deployment given the company’s swelling cash balance.
Stocks making the biggest moves midday: AeroVironment, Nvidia, AES, Coherent, Norwegian Cruise Line & more

Here are some of the stocks making the biggest moves in midday trading.
Nvidia’s stock is stuck. Morgan Stanley says it’s time to buy again

Morgan Stanley sees shares of Nvidia rallying 47% from current levels.
Iran war prediction market bets draw heat: ‘Insane this is legal’

Wagers were placed over the weekend about the fate of Iranian leader Ayatollah Ali Khamenei who was killed in the bombardment.
Josh Brown highlights three chemical stocks as U.S.-Iran conflict rattles global markets

Chemicals has been an area of strength recently, but they will pull back if the market gets nervous about whatever’s about to happen in Iran, says Josh Brown.
Citadel’s various hedge funds rise in February, beating the S&P 500 in a choppy month

The firm’s flagship multistrategy Wellington fund rose 1.9% in February, bringing its year-to-date gain to 2.9%.